{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06324201",
            "orgStudyIdInfo": {
                "id": "QDOT PAS"
            },
            "organization": {
                "fullName": "Heart Rhythm Clinical and Research Solutions, LLC",
                "class": "OTHER"
            },
            "briefTitle": "The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.",
            "officialTitle": "The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO\u2122 System Use in Conjunction With VISITAG SURPOINT\u2122Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation",
            "acronym": "QDOT PAS",
            "therapeuticArea": [
                "Other"
            ],
            "study": "the-long-term-safety-and-effectiveness-evaluation-of-the-qdot-micro-system-use-in-conjunction-with-visitag-surpoint-module-for-the-treatment-of-symptomatic-drug-refractory-paroxysmal-atrial-fibrillation"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-02-27",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-03",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-03",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-02-21",
            "studyFirstSubmitQcDate": "2024-03-19",
            "studyFirstPostDateStruct": {
                "date": "2024-03-21",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-19",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-21",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Heart Rhythm Clinical and Research Solutions, LLC",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Biosense Webster, Inc.",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Observational, multi-center, non-randomized, post-market study. This is a nested sub-study of the REAL AF Registry. Consecutive symptomatic drug refractory paroxysmal atrial fibrillation (PAF) patients from the registry will be screened for enrollment to this sub-study per inclusion and exclusion criteria.",
            "detailedDescription": "Enrolled QDOT PAS subjects are defined as consented patients with symptomatic paroxysmal atrial fibrillation (PAF) enrolled in the REAL AF registry. These enrolled subjects will be treated with the commercially available QDOT MICRO\u2122 system (QDOT MICRO\u2122 catheter and nGEN\u2122 generator) in conjunction with VISITAG SURPOINT\u2122 Module. Subjects are required to complete scheduled assessments within 12 months of the index procedure, and additional two assessments at 24 and 36-months post procedure."
        },
        "conditionsModule": {
            "conditions": [
                "Paroxysmal Atrial Fibrillation"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "CASE_ONLY",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 250,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "Ablation Procedure",
                    "description": "Ablation Procedure for paroxysmal atrial fibrillation"
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Safety of the QDOT Micro System use in conjunction with VISITAG SURPOINT Module",
                    "description": "Adverse events from post-procedure through 7-day post ablation visit.",
                    "timeFrame": "Day 0-7 post ablation"
                },
                {
                    "measure": "Effectiveness of the QDOT Micro System use in conjunction with VISITAG SURPOINT Module at 12-months.",
                    "description": "Freedom from atrial arrhythmia recurrence at 12 months post procedure.",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Effectiveness of the QDOT Micro System use in conjunction with VISITAG SURPOINT Module at 24-months.",
                    "description": "Freedom from atrial arrhythmia recurrence at 24 months post procedure.",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "Effectiveness of the QDOT Micro System use in conjunction with VISITAG SURPOINT Module at 36-months.",
                    "description": "Freedom from atrial arrhythmia recurrence at 36 months post procedure.",
                    "timeFrame": "36 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Symptomatic drug refractory paroxysmal (AF episode terminate spontaneously within 7 days) who, in the opinion of the investigator, are candidates for ablation for AF\n2. 18 years of age or older\n3. Able and willing to participate in baseline and follow up evaluations for the full length of the sub-study\n4. Willing and able to provide informed consent for this sub-study\n\nExclusion Criteria:\n\n1. Patients who have undergone catheter ablation for atrial fibrillation (PVI, roof line, posterior wall ablation...)\n2. Enrolled in an investigational drug or device clinical trial, or any trial that dictates the treatment plan\n3. Persistent or long-standing persistent AF\n4. In the opinion of the investigator, any known contraindication to an ablation procedure",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Study population will consist of patients in the REAL AF registry who have symptomatic PAF and undergo ablation procedures using the QDOT MICRO\u2122 System with VISITAG SURPOINT\u2122 Module",
            "samplingMethod": "PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Carla Perna",
                    "role": "CONTACT",
                    "phone": "205-223-0960",
                    "email": "cperna@hrcrs.com"
                }
            ],
            "locations": [
                {
                    "facility": "Centra Health, Inc.dba Stroobants Cardiovascular Center",
                    "status": "RECRUITING",
                    "city": "Lynchburg",
                    "state": "Virginia",
                    "zip": "24501",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Cindy Baumann",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Mathhew Sackett",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.41375,
                        "lon": -79.14225
                    }
                },
                {
                    "facility": "Mercy Health",
                    "status": "RECRUITING",
                    "city": "Janesville",
                    "state": "Wisconsin",
                    "zip": "53548",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kaitlyn Phetteplace",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Imdad Ahmed",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.68279,
                        "lon": -89.01872
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001281",
                    "term": "Atrial Fibrillation"
                }
            ],
            "ancestors": [
                {
                    "id": "D000001145",
                    "term": "Arrhythmias, Cardiac"
                },
                {
                    "id": "D000006331",
                    "term": "Heart Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4586",
                    "name": "Atrial Fibrillation",
                    "asFound": "Paroxysmal Atrial Fibrillation",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4453",
                    "name": "Arrhythmias, Cardiac",
                    "relevance": "LOW"
                },
                {
                    "id": "M9419",
                    "name": "Heart Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}